Nagy F - Search Results

1

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.

Prépost E, Tóth Z, Perlin DS, Gesztelyi R, Kardos G, Kovács R, Nagy F, Forgács L, Majoros L. Prépost E, et al. Among authors: nagy f. Infect Drug Resist. 2019 Jul 1;12:1805-1814. doi: 10.2147/IDR.S198764. eCollection 2019. Infect Drug Resist. 2019. PMID: 31303773 Free PMC article.

2

Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.

Kovács R, Bozó A, Gesztelyi R, Domán M, Kardos G, Nagy F, Tóth Z, Majoros L. Kovács R, et al. Among authors: nagy f. Int J Antimicrob Agents. 2016 Apr;47(4):304-10. doi: 10.1016/j.ijantimicag.2016.01.007. Epub 2016 Feb 17. Int J Antimicrob Agents. 2016. PMID: 26968084

3

Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.

Kovács R, Tóth Z, Nagy F, Daróczi L, Bozó A, Majoros L. Kovács R, et al. Among authors: nagy f. J Appl Microbiol. 2017 Jun;122(6):1529-1536. doi: 10.1111/jam.13452. Epub 2017 May 3. J Appl Microbiol. 2017. PMID: 28321957 Free article.

4

In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.

Nagy F, Bozó A, Tóth Z, Daróczi L, Majoros L, Kovács R. Nagy F, et al. Med Mycol. 2018 Jun 1;56(4):493-500. doi: 10.1093/mmy/myx062. Med Mycol. 2018. PMID: 28992253

5

Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.

Kardos T, Kovács R, Kardos G, Varga I, Bozó A, Tóth Z, Nagy F, Majoros L. Kardos T, et al. Among authors: nagy f. J Chemother. 2018 Jul;30(4):233-239. doi: 10.1080/1120009X.2018.1487150. Epub 2018 Jul 20. J Chemother. 2018. PMID: 30025501

6

Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.

Nemes D, Kovács R, Nagy F, Mező M, Poczok N, Ujhelyi Z, Pető Á, Fehér P, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I. Nemes D, et al. Among authors: nagy f. Molecules. 2018 Jul 23;23(7):1827. doi: 10.3390/molecules23071827. Molecules. 2018. PMID: 30041418 Free PMC article.

7

Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.

Nagy F, Tóth Z, Bozó A, Czeglédi A, Rebenku I, Majoros L, Kovács R. Nagy F, et al. Med Mycol. 2019 Jul 1;57(5):573-581. doi: 10.1093/mmy/myy108. Med Mycol. 2019. PMID: 30339227

8

Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.

Tóth Z, Kardos T, Kovács R, Kardos G, Nagy F, Prépost E, Barta Z, Takacs I, Majoros L. Tóth Z, et al. Among authors: nagy f. Mycopathologia. 2018 Dec;183(6):905-912. doi: 10.1007/s11046-018-0302-5. Epub 2018 Oct 31. Mycopathologia. 2018. PMID: 30382508

9

Farnesol increases the activity of echinocandins against Candida auris biofilms.

Nagy F, Tóth Z, Daróczi L, Székely A, Borman AM, Majoros L, Kovács R. Nagy F, et al. Med Mycol. 2020 Apr 1;58(3):404-407. doi: 10.1093/mmy/myz057. Med Mycol. 2020. PMID: 31127836

10

Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.

Kovács R, Nagy F, Tóth Z, Bozó A, Balázs B, Majoros L. Kovács R, et al. Among authors: nagy f. Lett Appl Microbiol. 2019 Oct;69(4):271-278. doi: 10.1111/lam.13204. Epub 2019 Aug 23. Lett Appl Microbiol. 2019. PMID: 31385615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

609 results

Search Page